Terms: = Thyroid cancer AND PAM50
2 results:
1. Overall Survival for HER2-Positive Breast cancer Patients in the HER2-Targeted Era: Evidence From a Population-Based Study.
Marczyk VR; Rosa DD; Maia AL; Goemann IM
Clin Breast Cancer; 2022 Jul; 22(5):418-423. PubMed ID: 35430163
[TBL] [Abstract] [Full Text] [Related]
2. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.
Bolf EL; Gillis NE; Davidson CD; Cozzens LM; Kogut S; Tomczak JA; Frietze S; Carr FE
Mol Carcinog; 2021 Dec; 60(12):874-885. PubMed ID: 34534367
[TBL] [Abstract] [Full Text] [Related]
